Document Detail


The inhibitory effect of genistein on hepatic steatosis is linked to visceral adipocyte metabolism in mice with diet-induced non-alcoholic fatty liver disease.
MedLine Citation:
PMID:  20687969     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Non-alcoholic fatty liver disease (NAFLD) has been deeply associated with visceral adiposity, adipose tissue inflammation and a variety of adipocytokines. We reported previously that genistein inhibited NAFLD by enhancing fatty acid catabolism. However, this molecular approach focused on hepatic metabolism. Thus, we have attempted to determine whether this anti-steatotic effect of genistein is linked to visceral adipocyte metabolism. C57BL/6J mice were fed on normal-fat (NF) diet, high-fat (HF) diet and HF diet supplemented with genistein (1, 2 and 4 g/kg diet) for 12 weeks. Mice fed on the HF diet gained body weight, exhibited increased visceral fat mass and elevated levels of serum and liver lipids, and developed NAFLD, unlike what was observed in mice fed on the NF diet. However, genistein supplementation (2 and 4 g/kg diet) normalised these alternations. In the linear regression analysis, visceral fat (R 0·77) and TNFα (R 0·62) were strongly correlated with NAFLD among other NAFLD-related parameters. Genistein supplementation suppressed the hypertrophy of adipocytes via the up-regulation of genes involved in fatty acid β-oxidation, including PPARα, 5'-AMP-activated protein kinase and very long-chain acyl CoA dehydrogenase, as well as through the down-regulation of genes associated with adipogenesis or lipogenesis, including liver X receptor-α, sterol-regulatory element-binding protein-1c, PPARγ, retinoid X receptor-α and acetyl CoA carboxylase 2. Moreover, genistein supplementation augmented an anti-steatohepatitic adiponectin TNF and reduced a steatohepatitic TNFα. Collectively, these findings show that genistein may prevent NAFLD via the regulation of visceral adipocyte metabolism and adipocytokines.
Authors:
Mi-Hyun Kim; Kyung-Sun Kang; Yeon-Sook Lee
Related Documents :
1337909 - Effect of dietary fat and fiber on fecal flora, bacterial metabolites, and fecal proper...
9628529 - Nutritional aspects of hydrogenated and regular soybean oil added to diets of broiler c...
12052479 - Correction of long-term diet-induced hypertension and nitrotyrosine accumulation by die...
20102899 - Baseline low-density lipoprotein cholesterol levels and outcome in patients with heart ...
3006519 - Dissociation of sympathetic and thermogenic activity in brown fat of syrian hamsters.
17639019 - Phosphorylation barriers to skeletal and cardiac muscle glucose uptakes in high-fat fed...
20012799 - Investigation of the effect of high dairy diet on body mass index and body fat in overw...
16507699 - Effects of dairy cow genotype with two planes of nutrition on energy partitioning betwe...
8028519 - The effects of weight loss by exercise or by dieting on plasma high-density lipoprotein...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-08-06
Journal Detail:
Title:  The British journal of nutrition     Volume:  104     ISSN:  1475-2662     ISO Abbreviation:  Br. J. Nutr.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-29     Completed Date:  2010-11-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372547     Medline TA:  Br J Nutr     Country:  England    
Other Details:
Languages:  eng     Pagination:  1333-42     Citation Subset:  IM    
Affiliation:
Department of Food and Nutrition, College of Human Ecology, Seoul National University, 599 Gwanangno, Gwanak-gu, Seoul 151-742, South Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adipocytes / metabolism,  pathology
Adipogenesis / genetics
Animals
Antilipemic Agents / pharmacology*,  therapeutic use
Dietary Fats / metabolism
Fatty Liver / drug therapy,  genetics,  metabolism*
Gene Expression Regulation / drug effects
Genistein / pharmacology*,  therapeutic use
Hypertrophy
Intra-Abdominal Fat / metabolism*
Linear Models
Lipid Metabolism*
Lipogenesis / genetics
Male
Mice
Mice, Inbred C57BL
Phytoestrogens / pharmacology,  therapeutic use
Plant Extracts / pharmacology*,  therapeutic use
Soybeans / chemistry
Tumor Necrosis Factors / metabolism
Weight Gain / drug effects
Chemical
Reg. No./Substance:
0/Antilipemic Agents; 0/Dietary Fats; 0/Phytoestrogens; 0/Plant Extracts; 0/Tumor Necrosis Factors; 446-72-0/Genistein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Genotoxic and carcinogenic risks associated with the dietary consumption of repeatedly heated coconu...
Next Document:  Effect of multifibre mixture with prebiotic components on bifidobacteria and stool pH in tube-fed ch...